Global Measles and Rubella (MR) Vaccine Market Growth 2022-2028
- LP 4968282
- 78 Pages
- June 2022
- Pharmaceuticals
The United States Measles and Rubella (MR) Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Measles and Rubella (MR) Vaccine market, reaching US$ million by the year 2028. As for the Europe Measles and Rubella (MR) Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Measles and Rubella (MR) Vaccine players cover PT Bio Farma, Bio-Manguinhos, BE Vaccines, and Crucell Switzerland AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Measles and Rubella (MR) Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
MR Vaccine
MRBEV Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Private Distribution Channel
Public Distribution Channel
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
PT Bio Farma
Bio-Manguinhos
BE Vaccines
Crucell Switzerland AG
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Measles and Rubella (MR) Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Measles and Rubella (MR) Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Measles and Rubella (MR) Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Measles and Rubella (MR) Vaccine Segment by Type
2.2.1 MR Vaccine
2.2.2 MRBEV Vaccine
2.3 Measles and Rubella (MR) Vaccine Sales by Type
2.3.1 Global Measles and Rubella (MR) Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Measles and Rubella (MR) Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Measles and Rubella (MR) Vaccine Sale Price by Type (2017-2022)
2.4 Measles and Rubella (MR) Vaccine Segment by Application
2.4.1 Private Distribution Channel
2.4.2 Public Distribution Channel
2.5 Measles and Rubella (MR) Vaccine Sales by Application
2.5.1 Global Measles and Rubella (MR) Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Measles and Rubella (MR) Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Measles and Rubella (MR) Vaccine Sale Price by Application (2017-2022)
3 Global Measles and Rubella (MR) Vaccine by Company
3.1 Global Measles and Rubella (MR) Vaccine Breakdown Data by Company
3.1.1 Global Measles and Rubella (MR) Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Measles and Rubella (MR) Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Measles and Rubella (MR) Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Measles and Rubella (MR) Vaccine Revenue by Company (2020-2022)
3.2.2 Global Measles and Rubella (MR) Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Measles and Rubella (MR) Vaccine Sale Price by Company
3.4 Key Manufacturers Measles and Rubella (MR) Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Measles and Rubella (MR) Vaccine Product Location Distribution
3.4.2 Players Measles and Rubella (MR) Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Measles and Rubella (MR) Vaccine by Geographic Region
4.1 World Historic Measles and Rubella (MR) Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Measles and Rubella (MR) Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Measles and Rubella (MR) Vaccine Annual Revenue by Geographic Region
4.2 World Historic Measles and Rubella (MR) Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Measles and Rubella (MR) Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Measles and Rubella (MR) Vaccine Annual Revenue by Country/Region
4.3 Americas Measles and Rubella (MR) Vaccine Sales Growth
4.4 APAC Measles and Rubella (MR) Vaccine Sales Growth
4.5 Europe Measles and Rubella (MR) Vaccine Sales Growth
4.6 Middle East & Africa Measles and Rubella (MR) Vaccine Sales Growth
5 Americas
5.1 Americas Measles and Rubella (MR) Vaccine Sales by Country
5.1.1 Americas Measles and Rubella (MR) Vaccine Sales by Country (2017-2022)
5.1.2 Americas Measles and Rubella (MR) Vaccine Revenue by Country (2017-2022)
5.2 Americas Measles and Rubella (MR) Vaccine Sales by Type
5.3 Americas Measles and Rubella (MR) Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Measles and Rubella (MR) Vaccine Sales by Region
6.1.1 APAC Measles and Rubella (MR) Vaccine Sales by Region (2017-2022)
6.1.2 APAC Measles and Rubella (MR) Vaccine Revenue by Region (2017-2022)
6.2 APAC Measles and Rubella (MR) Vaccine Sales by Type
6.3 APAC Measles and Rubella (MR) Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Measles and Rubella (MR) Vaccine by Country
7.1.1 Europe Measles and Rubella (MR) Vaccine Sales by Country (2017-2022)
7.1.2 Europe Measles and Rubella (MR) Vaccine Revenue by Country (2017-2022)
7.2 Europe Measles and Rubella (MR) Vaccine Sales by Type
7.3 Europe Measles and Rubella (MR) Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Measles and Rubella (MR) Vaccine by Country
8.1.1 Middle East & Africa Measles and Rubella (MR) Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Measles and Rubella (MR) Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Measles and Rubella (MR) Vaccine Sales by Type
8.3 Middle East & Africa Measles and Rubella (MR) Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Measles and Rubella (MR) Vaccine
10.3 Manufacturing Process Analysis of Measles and Rubella (MR) Vaccine
10.4 Industry Chain Structure of Measles and Rubella (MR) Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Measles and Rubella (MR) Vaccine Distributors
11.3 Measles and Rubella (MR) Vaccine Customer
12 World Forecast Review for Measles and Rubella (MR) Vaccine by Geographic Region
12.1 Global Measles and Rubella (MR) Vaccine Market Size Forecast by Region
12.1.1 Global Measles and Rubella (MR) Vaccine Forecast by Region (2023-2028)
12.1.2 Global Measles and Rubella (MR) Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Measles and Rubella (MR) Vaccine Forecast by Type
12.7 Global Measles and Rubella (MR) Vaccine Forecast by Application
13 Key Players Analysis
13.1 PT Bio Farma
13.1.1 PT Bio Farma Company Information
13.1.2 PT Bio Farma Measles and Rubella (MR) Vaccine Product Offered
13.1.3 PT Bio Farma Measles and Rubella (MR) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 PT Bio Farma Main Business Overview
13.1.5 PT Bio Farma Latest Developments
13.2 Bio-Manguinhos
13.2.1 Bio-Manguinhos Company Information
13.2.2 Bio-Manguinhos Measles and Rubella (MR) Vaccine Product Offered
13.2.3 Bio-Manguinhos Measles and Rubella (MR) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bio-Manguinhos Main Business Overview
13.2.5 Bio-Manguinhos Latest Developments
13.3 BE Vaccines
13.3.1 BE Vaccines Company Information
13.3.2 BE Vaccines Measles and Rubella (MR) Vaccine Product Offered
13.3.3 BE Vaccines Measles and Rubella (MR) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 BE Vaccines Main Business Overview
13.3.5 BE Vaccines Latest Developments
13.4 Crucell Switzerland AG
13.4.1 Crucell Switzerland AG Company Information
13.4.2 Crucell Switzerland AG Measles and Rubella (MR) Vaccine Product Offered
13.4.3 Crucell Switzerland AG Measles and Rubella (MR) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Crucell Switzerland AG Main Business Overview
13.4.5 Crucell Switzerland AG Latest Developments
14 Research Findings and Conclusion
Table 1. Measles and Rubella (MR) Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Measles and Rubella (MR) Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of MR Vaccine
Table 4. Major Players of MRBEV Vaccine
Table 5. Global Measles and Rubella (MR) Vaccine Sales by Type (2017-2022) & (Units)
Table 6. Global Measles and Rubella (MR) Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Measles and Rubella (MR) Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Measles and Rubella (MR) Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Measles and Rubella (MR) Vaccine Sales by Application (2017-2022) & (Units)
Table 11. Global Measles and Rubella (MR) Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Measles and Rubella (MR) Vaccine Revenue by Application (2017-2022)
Table 13. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Measles and Rubella (MR) Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Measles and Rubella (MR) Vaccine Sales by Company (2020-2022) & (Units)
Table 16. Global Measles and Rubella (MR) Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Measles and Rubella (MR) Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Measles and Rubella (MR) Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Measles and Rubella (MR) Vaccine Producing Area Distribution and Sales Area
Table 21. Players Measles and Rubella (MR) Vaccine Products Offered
Table 22. Measles and Rubella (MR) Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Measles and Rubella (MR) Vaccine Sales by Geographic Region (2017-2022) & (Units)
Table 26. Global Measles and Rubella (MR) Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Measles and Rubella (MR) Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Measles and Rubella (MR) Vaccine Sales by Country/Region (2017-2022) & (Units)
Table 30. Global Measles and Rubella (MR) Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Measles and Rubella (MR) Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Measles and Rubella (MR) Vaccine Sales by Country (2017-2022) & (Units)
Table 34. Americas Measles and Rubella (MR) Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Measles and Rubella (MR) Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Measles and Rubella (MR) Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Measles and Rubella (MR) Vaccine Sales by Type (2017-2022) & (Units)
Table 38. Americas Measles and Rubella (MR) Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Measles and Rubella (MR) Vaccine Sales by Application (2017-2022) & (Units)
Table 40. Americas Measles and Rubella (MR) Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Measles and Rubella (MR) Vaccine Sales by Region (2017-2022) & (Units)
Table 42. APAC Measles and Rubella (MR) Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Measles and Rubella (MR) Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Measles and Rubella (MR) Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Measles and Rubella (MR) Vaccine Sales by Type (2017-2022) & (Units)
Table 46. APAC Measles and Rubella (MR) Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Measles and Rubella (MR) Vaccine Sales by Application (2017-2022) & (Units)
Table 48. APAC Measles and Rubella (MR) Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Measles and Rubella (MR) Vaccine Sales by Country (2017-2022) & (Units)
Table 50. Europe Measles and Rubella (MR) Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Measles and Rubella (MR) Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Measles and Rubella (MR) Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Measles and Rubella (MR) Vaccine Sales by Type (2017-2022) & (Units)
Table 54. Europe Measles and Rubella (MR) Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Measles and Rubella (MR) Vaccine Sales by Application (2017-2022) & (Units)
Table 56. Europe Measles and Rubella (MR) Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Measles and Rubella (MR) Vaccine Sales by Country (2017-2022) & (Units)
Table 58. Middle East & Africa Measles and Rubella (MR) Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Measles and Rubella (MR) Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Measles and Rubella (MR) Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Measles and Rubella (MR) Vaccine Sales by Type (2017-2022) & (Units)
Table 62. Middle East & Africa Measles and Rubella (MR) Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Measles and Rubella (MR) Vaccine Sales by Application (2017-2022) & (Units)
Table 64. Middle East & Africa Measles and Rubella (MR) Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Measles and Rubella (MR) Vaccine
Table 66. Key Market Challenges & Risks of Measles and Rubella (MR) Vaccine
Table 67. Key Industry Trends of Measles and Rubella (MR) Vaccine
Table 68. Measles and Rubella (MR) Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Measles and Rubella (MR) Vaccine Distributors List
Table 71. Measles and Rubella (MR) Vaccine Customer List
Table 72. Global Measles and Rubella (MR) Vaccine Sales Forecast by Region (2023-2028) & (Units)
Table 73. Global Measles and Rubella (MR) Vaccine Sales Market Forecast by Region
Table 74. Global Measles and Rubella (MR) Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Measles and Rubella (MR) Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Measles and Rubella (MR) Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 77. Americas Measles and Rubella (MR) Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Measles and Rubella (MR) Vaccine Sales Forecast by Region (2023-2028) & (Units)
Table 79. APAC Measles and Rubella (MR) Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Measles and Rubella (MR) Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 81. Europe Measles and Rubella (MR) Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Measles and Rubella (MR) Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 83. Middle East & Africa Measles and Rubella (MR) Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Measles and Rubella (MR) Vaccine Sales Forecast by Type (2023-2028) & (Units)
Table 85. Global Measles and Rubella (MR) Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Measles and Rubella (MR) Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Measles and Rubella (MR) Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Measles and Rubella (MR) Vaccine Sales Forecast by Application (2023-2028) & (Units)
Table 89. Global Measles and Rubella (MR) Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Measles and Rubella (MR) Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Measles and Rubella (MR) Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. PT Bio Farma Basic Information, Measles and Rubella (MR) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. PT Bio Farma Measles and Rubella (MR) Vaccine Product Offered
Table 94. PT Bio Farma Measles and Rubella (MR) Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. PT Bio Farma Main Business
Table 96. PT Bio Farma Latest Developments
Table 97. Bio-Manguinhos Basic Information, Measles and Rubella (MR) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Bio-Manguinhos Measles and Rubella (MR) Vaccine Product Offered
Table 99. Bio-Manguinhos Measles and Rubella (MR) Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Bio-Manguinhos Main Business
Table 101. Bio-Manguinhos Latest Developments
Table 102. BE Vaccines Basic Information, Measles and Rubella (MR) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. BE Vaccines Measles and Rubella (MR) Vaccine Product Offered
Table 104. BE Vaccines Measles and Rubella (MR) Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. BE Vaccines Main Business
Table 106. BE Vaccines Latest Developments
Table 107. Crucell Switzerland AG Basic Information, Measles and Rubella (MR) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Crucell Switzerland AG Measles and Rubella (MR) Vaccine Product Offered
Table 109. Crucell Switzerland AG Measles and Rubella (MR) Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Crucell Switzerland AG Main Business
Table 111. Crucell Switzerland AG Latest Developments
List of Figures
Figure 1. Picture of Measles and Rubella (MR) Vaccine
Figure 2. Measles and Rubella (MR) Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Measles and Rubella (MR) Vaccine Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Measles and Rubella (MR) Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Measles and Rubella (MR) Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of MR Vaccine
Figure 10. Product Picture of MRBEV Vaccine
Figure 11. Global Measles and Rubella (MR) Vaccine Sales Market Share by Type in 2021
Figure 12. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Measles and Rubella (MR) Vaccine Consumed in Private Distribution Channel
Figure 14. Global Measles and Rubella (MR) Vaccine Market: Private Distribution Channel (2017-2022) & (Units)
Figure 15. Measles and Rubella (MR) Vaccine Consumed in Public Distribution Channel
Figure 16. Global Measles and Rubella (MR) Vaccine Market: Public Distribution Channel (2017-2022) & (Units)
Figure 17. Global Measles and Rubella (MR) Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Application in 2021
Figure 19. Measles and Rubella (MR) Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Measles and Rubella (MR) Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Measles and Rubella (MR) Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Measles and Rubella (MR) Vaccine Sales 2017-2022 (Units)
Figure 26. Americas Measles and Rubella (MR) Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Measles and Rubella (MR) Vaccine Sales 2017-2022 (Units)
Figure 28. APAC Measles and Rubella (MR) Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Measles and Rubella (MR) Vaccine Sales 2017-2022 (Units)
Figure 30. Europe Measles and Rubella (MR) Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Measles and Rubella (MR) Vaccine Sales 2017-2022 (Units)
Figure 32. Middle East & Africa Measles and Rubella (MR) Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Measles and Rubella (MR) Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Measles and Rubella (MR) Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Measles and Rubella (MR) Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Measles and Rubella (MR) Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Measles and Rubella (MR) Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Measles and Rubella (MR) Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Measles and Rubella (MR) Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Measles and Rubella (MR) Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Measles and Rubella (MR) Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Measles and Rubella (MR) Vaccine
Figure 63. Industry Chain Structure of Measles and Rubella (MR) Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
